rolapitant: Clinical Trials

3 trials of rolapitant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3

Follow rolapitant: new trials by email Literature Review of rolapitant trials Research Report on rolapitant

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy
Rolapitant, Granisetron, dexamethasone - Chemotherapy-induced Nausea and Vomiting
Phase 3CompletedTesaro, Inc.5322012-02-012016-05-19
Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy
Rolapitant, Granisetron, Dexamethasone - Chemotherapy-induced Nausea and Vomiting
Phase 3CompletedTesaro, Inc.5552012-02-012016-03-02
Ph 3 Safety/Efficacy Study of Rolapitant for Prevention of CINV in Subjects Receiving Moderately Emetogenic Chemotherapy
Rolapitant, Granisetron, Dexamethasone - Chemotherapy-induced Nausea and Vomiting
Phase 3CompletedTesaro, Inc.13692012-02-012016-03-02

Conditions studied

Nausea (3)  ·  Vomiting (3)

Sponsors

Tesaro, Inc. (3)

Countries

United States (3)

Top investigators

Dennis Vargo, MD (3)

Results publications

PMID 26272769, PMID 26272768